Publicaciones en colaboración con investigadores/as de Stanford University (11)

2023

  1. In situ tumour arrays reveal early environmental control of cancer immunity

    Nature, Vol. 618, Núm. 7966, pp. 827-833

2021

  1. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

    Nature, Vol. 590, Núm. 7846, pp. 504-508

2019

  1. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Nature Medicine, Vol. 25, Núm. 11, pp. 1783-1795

  2. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

    Neurotherapeutics, Vol. 16, Núm. 3, pp. 808-827

2017

  1. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8

2016

  1. Impact of surgery for stage IA non-smallcell lung cancer on patient quality of life

    Journal of Community and Supportive Oncology, Vol. 14, Núm. 1, pp. 37-44

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. A meta-Analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma

    Cancer Research, Vol. 74, Núm. 10, pp. 2892-2902

  2. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2012

  1. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E

    Cancer Research, Vol. 72, Núm. 12, pp. 3048-3059